Cogent Biosciences, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
COGT on Nasdaq
Industry
Pharmaceutical Preparations
Location
275 Wyman Street, 3 Rd Floor, Waltham, MA

Insiders trading volume in the past year

Cogent Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fairmount Funds Management LLC Director $46.7M Jun 10, 2024
Cole Pinnow Chief Commercial Officer $348K +$332K +2085% Jan 23, 2025
Arlene Morris Director Jun 5, 2024
Todd Shegog Director Jun 5, 2024
Matthew Ros Director Jun 5, 2024
Peter Evan Harwin Director Jun 5, 2024
Karen Jean Ferrante Director Jan 1, 2025
Jessica Sachs Chief Medical Officer Jan 23, 2025
John Edward Robinson Chief Scientific Officer Jan 23, 2025
Evan Kearns Chief Legal Officer Jan 23, 2025
John L. Green Chief Financial Officer Jan 23, 2025
Christopher W. Cain Director Jun 5, 2024
Andrew R. Robbins President and CEO, Director Jan 23, 2025

Recent Insider Transactions by Companies or Individuals for Cogent Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.